U ltrasound biomicroscopy (UBM) has dramatically improved resolution of anterior segment tumours, from 300-400 mm with conventional 10 MHz ultrasonography down to 20-50 mm with tissue penetration of up to 4 mm. 1 This technique allows for in vivo high resolution imaging of anterior segment masses with biometry and assessment of adjacent tissue invasion. [1] [2] [3] [4] Recent series have demonstrated a high correlation between UBM features of anterior uveal melanomas (UM) and histopathological features, including local extension. 4 Historically biopsy, resection, or enucleation were the main options for diagnosis or treatment of anterior segment malignancy. In many cases, UBM allows for definitive diagnosis and more conservative management, with comparable or better outcomes. 2 We describe our experience with UBM in managing 130 patients referred to an ocular oncology centre for evaluation of suspected anterior segment tumours.
METHODS
Medical records of consecutive patients referred to the University of California San Francisco ocular oncology unit between January 1999 and July 2004 for evaluation of anterior segment tumours were reviewed. Patients underwent a complete ophthalmic evaluation including gonioscopy, slit lamp photography, and iris fluorescein angiography. Where clinically indicated, A/B-scan ultrasonography was performed in selected patients. A/B ultrasounds were evaluated by two ophthalmologists (JO/RMC) experienced in their interpretation.
UBM was carried out utilising a 50 MHz commercially available device (Zeiss Humphrey, San Leandro, CA, USA) using an eye cup with methylcellulose medium. UBM examinations were performed by one ophthalmologist with extensive UBM experience (SL). Both maximal tumour thickness and maximal tumour diameter were documented on each occasion by multiple radial and cross sectional measurements.
To compare A/B-scan ultrasound with UBM, observers were blinded to the patients' data. Two observers experienced in A/B-scan and UBM interpretation independently performed the analysis (RMC/JO). Features assessed included the anatomical structures invaded by tumour. Fisher's exact test was used to test for statistically significant associations between unpaired data.
RESULTS
A total of 130 patients were identified (table 1) . Seventy per cent of lesions were referred as melanomas, but demonstrated neuroepithelial cysts on UBM. In 93% of these, UBM was required to make the diagnosis (table 2, fig 1) . Neuroepithelial cysts coexisted with naevi (n = 2) and ciliary body (CB) melanoma (n = 1) (fig 1) .
Thirty nine solid iris lesions were initially observed (mean follow up 28 months, range 9-58 months) by serial photography and UBM biometry. Eighteen showed growth and were reclassified as melanoma and underwent proton beam radiotherapy (PBT) (table 2, fig 2) . Additionally, all had one or more other features of malignancy. 5 CB invasion was detected in 14 cases (table 3, fig 2) . The remaining 21 cases showed no growth by UBM (mean follow up 26 months) and were characterised as naevi.
Sixteen CB melanomas were identified ( ; 12 presented with visual loss secondary to lens subluxation, cataract, glaucoma, or retinal detachment. Extrascleral extension (n = 1) and ring configuration (n = 1) were also encountered. Iris invasion was observed by UBM in eight patients (table 3) . CB melanomas were managed by enucleation or PBT. In all enucleated specimens (n = 6) there was good correlation between UBM and histopathology defining disease extent.
Twenty one patients were referred with anterior choroidal tumours. All were pigmented and had B-scan features consistent with melanoma. 6 UBM excluded CB involvement in 13 cases and confirmed involvement in eight (table 3). All were treated by PBT after tantalum marker clip placement. For all tumours with CB involvement, intraoperative UBM was used to evaluate margins.
Patients treated by PBT (n = 57) were followed at our institution (mean follow up 26 months; range 6-55 months). Follow up included 3-6 monthly examination, photography, fluorescein angiography, UBM, and A/B-scan. Three patients with CB melanoma and one with choroidal melanoma demonstrated marginal recurrence by UBM. In one patient treated elsewhere by brachytherapy, trans-scleral extension was detected. He refused enucleation and was re-treated by PBT. The remaining patients underwent secondary enucleation. Histopathology confirmed the UBM findings of incomplete treatment.
There was 29% correspondence between anatomical structures involved by tumour identified by A/B-scan v UBM. CB involvement was identified more frequently by UBM v A/B-scan in iris melanoma (p,0.01) and choroidal melanoma (p = 0.02). Iris involvement was identified in eight cases of CB melanoma v one case identified by A/B-scan (p = 0.02) (table 3). ÀOther diagnoses included scleromalacia (n = 8), metastatic lesions (n = 4), peripheral anterior synechiae (n = 3), iris vascular malformation (n = 3), traumatic cyst (n = 2), recurrent retinoblastoma (n = 2), iridocorneal endothelial syndrome (n = 1), leiomyoma (n = 1), and no mass detected (n = 2). 
DISCUSSION
The present study is the largest describing the use of UBM in consecutive ocular oncology patients. Most patients were referred by ophthalmologists who suspected the ocular lesion was a neoplasm. The high incidence of melanoma in our series (42%) probably reflects this referral bias. Neuroepithelial cysts most commonly simulated iridociliary melanoma and UBM appearance was diagnostic in most cases. [7] [8] [9] [10] However, the presence of a cyst does not exclude coexisting pathology. Identification of a solid CB mass associated with a thin walled cyst in one patient distinguished this mass as a melanoma (fig 1) . This highlights the need for careful evaluation to exclude any solid component in an apparently benign cyst. Glaucoma, peripheral anterior synechiae, plateau iris syndrome, and corneal touch have been reported as complications of iridociliary cysts. 7 9 In agreement with other series, we found these complications were uncommon and treatment rarely required. 10 Documented growth is the most important indicator of malignancy in differentiating iris naevi from melanoma. 5 11 UBM was an indispensable adjunct to photography for assessing growth, as both maximal thickness and diameter could be reliably measured, objectively validating this important feature. However, occasionally iris tumours displaying signs suggestive of malignancy have been reported to be histopathologically benign. 11 Invasion of the CB typically appears on UBM as an area of reduced reflectivity in continuity with the iris mass, and is diagnostically important as naevi do not usually involve this structure (fig 2) . 6 11 Additionally, iris melanoma involvement of the iris root is an independent risk factor for metastasis. 11 UBM of iris melanomas demonstrates a variable appearance, reflecting the clinical heterogeneity attributed to differences in lesion vascularity and cellularity. 12 Reflecting the tendency for tissue distortion by melanomas, irregularity of the posterior iris surface was associated with most iris melanomas in this study, however was rarely observed in naevi (see fig 2E) .
UBM is the only diagnostic tool which allows visualisation of small CB tumours. We were able to characterise and follow one patient with a CB tumour with a maximal diameter of 1.7 mm (fig 3D) . Serial UBM demonstrated growth in this lesion including early invasion of the iris root. The main differential diagnoses include other pigmented CB tumours such as melanocytomas and pigment epithelial adenomas/ adenocarcinomas. 13 These entities can be difficult to differentiate clinically and on UBM. All may appear as well defined CB masses with low to high internal reflectivity and invasive features. 6 13 In practice, many CB tumours remain undetected until they are relatively large in size, when they present symptomatically and require A/B-scan ultrasound to obtain accurate characterisation.
The estimated frequency of microscopic cavitation in uveal melanomas is 8.4%. 14 15 In rare instances, gross cavitation may occur, resulting in pseudocyst formation and confusion clinically and on A/B-scan with benign cysts. 14 15 We observed two CB melanomas with cavitation, one with pseudocyst formation (fig 3C, E, F) . According to the largest reported series, compared to epithelial cysts, cavitating uveal melanomas tend to be larger (base: 8-15 mm/thickness: 2.2-14.1 mm) and the pseudocyst wall is thicker (thinnest region: 0.4 mm) with medium reflectivity.
14 UBM analysis of our patient allowed the solid component and irregularly thickened wall to be appreciated.
Ring melanomas often present atypically with glaucoma, retinal dialysis, or heterochromia. 16 A discrete mass is frequently not appreciated on examination, leading to delayed diagnosis. 16 Tumour thickness can vary at different CB locations, causing the ring configuration of the tumour to be difficult to appreciate by A/B-scan, especially if the tumour is ,4 mm thick. As enucleation rather than conservative treatment is the management of choice for ring melanoma, we routinely survey the entire CB by sequential UBM clock hour imaging in cases of suspected iris or CB melanoma, or in cases where an underlying ring could be responsible for other atypical ocular findings. 16 Precise definition of tumour margins is crucial for successful conservative management of anterior UM. 5 17 Improved tumour localisation allows tighter therapeutic margins, reducing radiation exposure to surrounding tissues and potentially reducing treatment side effects. Intraoperative assessment of the extent of CB involvement by UM is particularly challenging. Transillumination can provide useful information; however, tumour melanin content, haemorrhage, and the degree of CB pigmentation can lead to inaccuracies. The present study demonstrates that UBM identifies CB involvement by adjacent melanomas significantly more often than A/B ultrasound. The accuracy of UBM in defining tumour margins is supported by studies which have demonstrated a high correlation (approximately 70%) between margins in the iris and CB defined by UBM compared to histopathological margins on enucleated specimens. 4 18 19 In cases where UBM did not correlate with histopathological margins, UBM tended to overestimate the anterior tumour margin. 4 We have found UBM very useful in defining anterior tumour margins and now use it as a routine intraoperative tool. Fifty seven patients were followed after PBT. In four cases we found evidence of re-growth, the remaining tumours displaying stable or decreased dimensions. All were CB tumours that had been treated before our current practice of using UBM intraoperatively. In one case we were able to completely define the extent of trans-scleral recurrence with intraoperative UBM and retreat with PBT and scleral patch graft. This patient remains in complete remission with stable best corrected vision of 20/60 at 55 months follow up.
A/B-scan ultrasonography remains an essential component in evaluating tumours for posterior extension and larger melanomas that cannot be fully evaluated by UBM. A/B-scan can also be used to demonstrate features characteristic of melanoma including low internal reflectivity, internal acoustic hollowness and sound attenuation, choroidal excavation, orbital shadowing and the presence of spontaneous vascular pulsations. 6 In some instances, the internal acoustic pattern obtained by conventional ultrasound will allow differentiation of the lesion (for example, melanoma v haemangioma) not possible with UBM. 6 There may be limitations to the use of UBM based on availability and user familiarity and, in these instances, A/B-scan may be of more use when correlated with clinical data.
In conclusion, UBM is very useful for anterior segment tumour management. The ability to characterise cystic lesions is diagnostic in most cases. UBM also allows reliable biometry, providing objective assessment of lesion size. When serial observation is indicated, UBM can detect growth with greater precision. Finally, UBM is helpful in treatment planning, particularly in establishing anterior margins. bmjupdates+ bmjupdates+ is a unique and free alerting service, designed to keep you up to date with the medical literature that is truly important to your practice. bmjupdates+ will alert you to important new research and will provide you with the best new evidence concerning important advances in health care, tailored to your medical interests and time demands.
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